Send mail to Author

A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _    _    _    _____     __   __    _  __     ___    
| || | || | || | || |  __ \\   \ \\/ //  | |/ //   / _ \\  
| || | || | || | || | |  \ ||   \ ` //   | ' //   | / \ || 
| \\_/ || | \\_/ || | |__/ ||    | ||    | . \\   | \_/ || 
 \____//   \____//  |_____//     |_||    |_|\_\\   \___//  
  `---`     `---`    -----`      `-`'    `-` --`   `---`
 


Back to frontdoor view

OPUS4 Logo